AbCellera Biologics (STU:8QQ) Accumulated other comprehensive income (loss) : €-1.67 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is AbCellera Biologics Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. AbCellera Biologics's Accumulated other comprehensive income (loss) for the quarter that ended in Mar. 2024 was €-1.67 Mil.

AbCellera Biologics's quarterly Accumulated other comprehensive income (loss) declined from Sep. 2023 (€-1.37 Mil) to Dec. 2023 (€-1.58 Mil) and declined from Dec. 2023 (€-1.58 Mil) to Mar. 2024 (€-1.67 Mil).

AbCellera Biologics's annual Accumulated other comprehensive income (loss) declined from Dec. 2021 (€0.25 Mil) to Dec. 2022 (€-1.31 Mil) and declined from Dec. 2022 (€-1.31 Mil) to Dec. 2023 (€-1.58 Mil).

AbCellera Biologics Accumulated other comprehensive income (loss) Historical Data

The historical data trend for AbCellera Biologics's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AbCellera Biologics Accumulated other comprehensive income (loss) Chart

AbCellera Biologics Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accumulated other comprehensive income (loss)

Get a 7-Day Free Trial

0.25

-1.31

-1.58

AbCellera Biologics Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accumulated other comprehensive income (loss)	Get a 7-Day Free Trial															-1.89	-1.75	-1.37	-1.58	-1.67

AbCellera Biologics Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

AbCellera Biologics Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of AbCellera Biologics's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

AbCellera Biologics (STU:8QQ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AbCellera Biologics Inc (STU:8QQ) » Definitions » Accumulated other comprehensive income (loss)

Comparable Companies

Traded in Other Exchanges

ABCL:USA

Address

2215 Yukon Street, Vancouver, BC, CAN, V5Y 0A1

Website

https://www.abcellera.com

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the most effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and leading pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

AbCellera Biologics (STU:8QQ) Headlines

No Headlines